And here’s what else you need to know to Start Your Week Smart . Your day is busy. 5 Things is your one-stop shop for the ...

Recent health news highlights major developments in the pharmaceutical industry, covering GSK's progress in ovarian cancer ...

The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.

The FDA has granted approval for its first medication for certain patients with sleep apnea—the weight-loss drug Zepbound.

There are many breakthroughs in medicine regarding the treatment of obstructive sleep apnea, and a weight loss drug might ...

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

However, some weight loss methods can be challenging to maintain and may not yield healthy, long-term results. To address this, a specialist has shared five straightforward tips for achieving ...

Obesity is not just a weight issue — it’s a chronic ... abnormalities in the lipid profile, fatty liver and obstructive sleep apnea (presenting as fatigue, sleepiness, headaches, decreased ...

However, she enjoyed how the meals switched up every week. When she first started on her weight loss journey she was on the seven-day meal plan. She's lost 33kg. Picture: Supplied Less than a ...